Personalis, Inc. (PSNL) vs Veracyte, Inc. (VCYT)
Personalis, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. Veracyte, Inc. is the larger, with a market value of $3.9B against $1.8B — 2.2× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 31.5×. Veracyte, Inc. grew revenue faster over the last twelve months: 17.3% against −13.3%. Veracyte, Inc. has the higher net margin (20.4% vs −153.8%) and the higher return on invested capital (7.32% vs −317.5%). Across the 17 metrics below, Veracyte, Inc. leads on 17 and Personalis, Inc. on 0.
Valuation
Profitability
| Metric | PSNL | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 12.69% | 71.71% | 50.89% |
| Operating margin | (164.07%) | 18.82% | (8.57%) |
| Net margin | (153.84%) | 20.37% | (6.37%) |
| Free cash flow margin | (144.76%) | 29.54% | 0.00% |
| Return on equity | (50.32%) | 8.77% | (2.92%) |
| Return on assets | (37.55%) | 8.09% | (6.71%) |
| Return on invested capital | (317.48%) | 7.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack